ORLADEYO now first and only targeted oral prophylactic therapy for patients with HAE aged 2 and older – -Oral pellet formulation provides ...

ORLADEYO is now the first and only targeted oral prophylactic therapy for patients with HAE aged 2 and above. A capsule ...

Prophylactic medication after ileocaecal resection in patients with Crohn's disease reduces long-term rates of severe endoscopic recurrence and endoscopic or radiologic recurrence, serving as a ...

This is a video synopsis/summary of an Insights involving Allison Wheeler, MD. Wheeler addresses the nuanced considerations for implementing prophylaxis in patients with mild to moderate hemophilia A, ...

RESEARCH TRIANGLE PARK, N.C., June 06, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today presented findings from two patient surveys conducted to gain insights into patients’ ...

Friday, May 20, 2022 (San Diego, U.S.)—Research from the University of California released in Clinical Infectious Diseases demonstrates that ingestible sensor-enabled Truvada®, taken as pre-exposure ...

3D render of a man with strong pain in head – Grayscale Image Researchers compared the safety and efficacy of drugs indicated for preventing migraine. Calcitonin gene-related peptide or its receptor ...

Adverse event clusters present at dose-reduction in CLL patients on ibrutinib in the U.S. Veterans Health Administration. Prospective validation of a clinical tool developed with machine learning to ...

—Data presented at the 2020 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)— RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2020 (GLOBE NEWSWIRE) -- BioCryst ...

This year has seen the approval of several first-in-class therapies for HAE, but in a fragmented space, experts question ...